Lobbying

Blessing Corporate Services's latest lobbying report covers Q2 2026, at $18K. The four quarters Q4 2025–Q3 2026 total $54K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Blessing Corporate Services

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$54K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Blessing Corporate Services lobbying by quarter
Blessing Corporate Services lobbying by quarter
QuarterAmountReports
Q4 2022$18K1
Q1 2023$18K1
Q2 2023$18K1
Q3 2023$18K1
Q4 2023$18K1
Q1 2024$18K1
Q2 2024$18K1
Q3 2024$18K1
Q4 2024$18K1
Q1 2025$18K1
Q2 2025$18K1
Q3 2025$18K1
Q4 2025$18K1
Q1 2026$18K1
Q2 2026$18K1
Q3 2026$00

By issue

  • Health issues$270K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
MR. Charles Scholz$270K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/16for Q2MR. Charles Scholz$18K
04/16for Q1MR. Charles Scholz$18K
01/16for Q4 2025MR. Charles Scholz$18K
25/10/20for Q3 2025MR. Charles Scholz$18K
25/07/18for Q2 2025MR. Charles Scholz$18K
25/04/18for Q1 2025MR. Charles Scholz$18K
25/01/17for Q4 2024MR. Charles Scholz$18K
24/10/21for Q3 2024MR. Charles Scholz$18K
24/07/22for Q2 2024MR. Charles Scholz$18K
24/05/08for Q1 2024MR. Charles Scholz$18K
24/01/19for Q4 2023MR. Charles Scholz$18K
23/10/17for Q3 2023MR. Charles Scholz$18K
23/07/17for Q2 2023MR. Charles Scholz$18K
23/04/20for Q1 2023MR. Charles Scholz$18K
23/01/19for Q4 2022MR. Charles Scholz$18K